GRAD-1405

N/A

Report date: 2024/12/13 13:18:30

Base Information

Drug NameGRAD-1405
Drug Alias NameGRAD-1405
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionKRAS G12C inhibitorsKRAS G12D inhibitorsKRAS G12V inhibitors +[4] 
TargetsKRAS G12CKRAS G12DKRAS G12V
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGradalis Inc
China Registration ClassN/A

Develop Information

Active CompaniesGradalis Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsPancreatic NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A